L-Malic Acid → Sunitinib Malate
Reaction equation
[CH3:1][CH2:2][N:3]([CH2:6][CH2:7][NH:8][C:9]([C:11]1[C:15]([CH3:16])=[C:14](/[CH:17]=[C:18]2/[C:19]3[CH:24]=[C:23]([F:25])[CH:22]=[CH:21][C:20]=3[NH:26][C:27]/2=[O:28])[NH:13][C:12]=1[CH3:29])=[O:10])[CH2:4][CH3:5].[C:30]([OH:38])(=[O:37])[C@H:31]([CH2:33][C:34]([OH:36])=[O:35])[OH:32]>O>[CH3:1][CH2:2][N:3]([CH2:6][CH2:7][NH:8][C:9]([C:11]1[C:15]([CH3:16])=[C:14](/[CH:17]=[C:18]2/[C:19]3[CH:24]=[C:23]([F:25])[CH:22]=[CH:21][C:20]=3[NH:26][C:27]/2=[O:28])[NH:13][C:12]=1[CH3:29])=[O:10])[CH2:4][CH3:5].[CH2:33]([C:34]([OH:36])=[O:35])[C@H:31]([OH:32])[C:30]([OH:38])=[O:37]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
Composition L containing Sunitinib base and L-malic acid (10 mg) was weighed into a vial, then 10 μL of water was added and the blend was mixed by shaking the vial. The vial was closed and left at ambient temperature for 3 days until drying, obtaining form 1.
Workup
- additionwas added
- additionthe blend was mixed
- customThe vial was closed
- customuntil drying
- customobtaining form 1
Sources & evidence
- ORD record
- ord-9dca063d98314708989439a832a59a3c
- Source dataset
- uspto-grants-2013_12
- Patent number
- US08618309B2
Reaction notes
Loading…